Researchers found that about 44% of users reported at least one side effect, with gastrointestinal symptoms remaining the most common
Anyone prescribed topiramate should discuss these requirements with their prescriber
"*" indicates required fields Or call us directly: +1 213-325-3373 *Cagrilintide is an investigational medication that has completed Phase 3 clinical trials but is NOT yet FDA approved for commercial sale
Data sources Product added on foodiq Last edit of product page on foodiq
For patients, it is important to understand that use always depends on the specific medication, indication, availability, and medical suitability assessment
However, as the capacity of SDH-b continues to decline beyond a critical point, the compensatory mechanism of upregulating Complex I becomes insufficient